21 September 2023
Halma PLC 21 September 2023 Trading update Halma, the global group of life-saving technology companies focused on growing a safer, cleaner and healthier future,…
20 September 2023
20 September 2023 Alexion completes purchase and licence agreement for early-stage rare disease gene therapy portfolio from Pfizer Alexion, AstraZeneca Rare Disease, has completed…
20 September 2023 Interim Results for the six months ended 30 June 2023 Winsford, UK, 20 September 2023: Advanced Medical Solutions Group plc (AIM: AMS),…
M&G PLC 20 September 2023 20 September 2023 M&G plc half year 2023 results GOOD OPERATIONAL AND FINANCIAL PERFORMANCE WITH PROGRESS AGAINST CORE STRATEGIC PRIORITIES…
19 September 2023
19 September 2023 HENRY BOOT PLC (‘Henry Boot’, the ‘Company’ or the ‘Group’) Ticker: BOOT.L: Main market premium listing: FTSE: Real Estate Investment and…
European Commission authorises ViiV Healthcare’s Apretude (cabotegravir long-acting and tablets) for HIV prevention · Given as few as six times per year, cabotegravir has demonstrated superior efficacy…
19 September 2023 Concurrent Technologies PLC (the “Company”) Interim Results for the six months ended 30 June 2023 Concurrent Technologies PLC (AIM: CNC), a…
Renishaw plc 19 September 2023 Preliminary announcement of results for the year ended 30 June 2023 Solid performance in challenging…